TY - JOUR
T1 - Alternatively spliced forms of the α subunit of the epithelial sodium channel
T2 - Distinct sites for amiloride binding and channel pore
AU - Li, Xiao Jiang
AU - Xu, Ruo Hui
AU - Guggino, William B.
AU - Snyder, Solomon H.
PY - 1995/6
Y1 - 1995/6
N2 - The amiloride-sensitive epithelial sodium channel (ENAC) consists of at least three subunits, α, β, and γ. Sodium conductance occurs when only the α subunit is expressed in Xenopus oocytes, but it is greatly enhanced by coexpression of all three subunits. All three subunits have two transmembrane domains. Whether the amiloride binding site exists in the extracellular portion or a transmembrane domain has not been established. Using reverse transcription-polymerase chain reaction in rat taste tissues, we have identified two alternatively spliced transcripts of ENAC (αENACa and αENACb) with deletions of nucleotides that introduce a premature stop codon and may result in proteins shortened by 199 and 216 amino acids, respectively, at the carboxyl terminus. Genomic Southern blots indicate that a single gene accounts for αENAC and the alternatively spliced variants. Reverse transcription-polymerase chain reaction and RNase protection assays demonstrate that αENACa is expressed to a lesser extent than αENAC in kidney, lung, and taste tissues. αENACa differs from αENAC by a deletion in the second transmembrane domain. Despite this deletion, αENACa expression in transfected human embryonic kidney 293 cells or CV-1 cells augments [3H]phenamil binding. The [3H]phenamil binding of αENACa resembles that of αENAC, being inhibited more potently by phenamil (K(d) = 65 nM) than amiloride. Unlike αENAC, expression of αENACa in Xenopus oocytes fails to generate amiloride-sensitive Na+ or L+ currents. These results suggest that the amiloride binding site resides on the extracellular loop of the α subunit of ENAC and not the putative second transmembrane domain, which forms a channel pore. Heterogeneity in αENAC isoforms may contribute to the complexity of multimeric structures and functional variation of ENAC.
AB - The amiloride-sensitive epithelial sodium channel (ENAC) consists of at least three subunits, α, β, and γ. Sodium conductance occurs when only the α subunit is expressed in Xenopus oocytes, but it is greatly enhanced by coexpression of all three subunits. All three subunits have two transmembrane domains. Whether the amiloride binding site exists in the extracellular portion or a transmembrane domain has not been established. Using reverse transcription-polymerase chain reaction in rat taste tissues, we have identified two alternatively spliced transcripts of ENAC (αENACa and αENACb) with deletions of nucleotides that introduce a premature stop codon and may result in proteins shortened by 199 and 216 amino acids, respectively, at the carboxyl terminus. Genomic Southern blots indicate that a single gene accounts for αENAC and the alternatively spliced variants. Reverse transcription-polymerase chain reaction and RNase protection assays demonstrate that αENACa is expressed to a lesser extent than αENAC in kidney, lung, and taste tissues. αENACa differs from αENAC by a deletion in the second transmembrane domain. Despite this deletion, αENACa expression in transfected human embryonic kidney 293 cells or CV-1 cells augments [3H]phenamil binding. The [3H]phenamil binding of αENACa resembles that of αENAC, being inhibited more potently by phenamil (K(d) = 65 nM) than amiloride. Unlike αENAC, expression of αENACa in Xenopus oocytes fails to generate amiloride-sensitive Na+ or L+ currents. These results suggest that the amiloride binding site resides on the extracellular loop of the α subunit of ENAC and not the putative second transmembrane domain, which forms a channel pore. Heterogeneity in αENAC isoforms may contribute to the complexity of multimeric structures and functional variation of ENAC.
UR - http://www.scopus.com/inward/record.url?scp=0029041610&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029041610&partnerID=8YFLogxK
M3 - Article
C2 - 7603452
AN - SCOPUS:0029041610
SN - 0026-895X
VL - 47
SP - 1133
EP - 1140
JO - Molecular Pharmacology
JF - Molecular Pharmacology
IS - 6
ER -